We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Results 1 to 5 of 47



FTC Announces 2016 Thresholds Under HSR Act and Clayton Act

USA - January 25 2016 Last week, the FTC announced revisions to HSR Act and Clayton Act Section 8 thresholds, which it revises each January to account for inflation using…

Co-authors: John R Ingrassia, Christopher E Ondeck, Rhett R Krulla.


The FTC's first loss in nearly half a decade, illuminating the difficulties of prediction and the merits of litigating it

USA - October 14 2015 "Prophesy is a good line of business, but it is full of risks." Mark Twain could have been speaking about the FTC's recent challenge to a merger…

Co-authors: John R Ingrassia, Christopher E Ondeck, Alicia J Batts, David A. Munkittrick .


HSR enforcement continues swiftly: $240k settlement announced with FTC for failure to file

USA - October 1 2015 On the heels of the FTC's recent HSR passive investor exemption enforcement action comes another reminder that HSR compliance is not always clear…

Co-authors: John R Ingrassia, Christopher E Ondeck, Alicia J Batts.


Passive means passive! Missed HSR filing spurs antitrust enforcers' ire - but change may be coming

USA - September 2 2015 The Federal Trade Commission, in its latest enforcement action relating to Hart-Scott-Rodino Act compliance, reminds investors that strict adherence…

Co-authors: John R Ingrassia, Christopher E Ondeck.


First federal appellate court holds a noncash reverse payment subject to antitrust scrutiny: is the Third Circuit's decision in King Drug a turning point?

USA - July 9 2015 Recently, the Third Circuit issued the first federal appellate decision interpreting the Supreme Court's landmark decision in FTC v. Actavis, Inc…

Co-authors: John R Ingrassia, Andrew S Wellin, Christopher E Ondeck, Alicia J Batts.

Next »